Cargando…

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso

BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiono, Alfred B, Ouédraogo, Alphonse, Ogutu, Bernhards, Diarra, Amidou, Coulibaly, Sam, Gansané, Adama, Sirima, Sodiomon B, O’Neil, Gregory, Mukhopadhyay, Amitava, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599538/
https://www.ncbi.nlm.nih.gov/pubmed/23442748
http://dx.doi.org/10.1186/1475-2875-12-79
_version_ 1782262985901735936
author Tiono, Alfred B
Ouédraogo, Alphonse
Ogutu, Bernhards
Diarra, Amidou
Coulibaly, Sam
Gansané, Adama
Sirima, Sodiomon B
O’Neil, Gregory
Mukhopadhyay, Amitava
Hamed, Kamal
author_facet Tiono, Alfred B
Ouédraogo, Alphonse
Ogutu, Bernhards
Diarra, Amidou
Coulibaly, Sam
Gansané, Adama
Sirima, Sodiomon B
O’Neil, Gregory
Mukhopadhyay, Amitava
Hamed, Kamal
author_sort Tiono, Alfred B
collection PubMed
description BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS: Eighteen villages were randomized (1:1) to study arms and inhabitants participated in four community screening campaigns: three before the rainy season ~1 month apart, and the fourth after the rains at ~12 months. On day 1 of campaigns 1–3, asymptomatic carriers in the intervention arm were identified by rapid diagnostic test and treated with artemether-lumefantrine. Outcomes were symptomatic malaria with parasite density >5,000/μL per person-year in children < 5 years and change in haemoglobin between days 1 and 28 of campaign 1. RESULTS: At 12 months, the number of symptomatic malaria episodes with a parasite density >5,000/μL per person-year in children < 5 years was not significantly different between arms (1.69 vs 1.60, p = 0.3482). Mean haemoglobin change in asymptomatic carriers during campaign 1 was greater in the intervention vs control arm (+0.53 g/dL vs -0.21 g/dL, p < 0.0001). ANCOVA demonstrated that mean asymptomatic carriage at the cluster level was lower in the intervention vs control arm at day 1 of campaigns 2 (5.0% vs 34.9%, p < 0.0001) and 3 (3.5% vs 31.5%, p < 0.0001), but showed only a small difference at day 1 of campaign 4 (34.6% vs 37.6%, p = 0.2982). Mean gametocyte carriage was lower in the intervention vs control arm at day 1 of campaigns 2 and 3 (0.7% vs 5.4%, p < 0.0001; 0.5% vs 5.8%, p < 0.0001), but was similar at day 1 of campaign 4 (4.9% vs 5.1%, p = 0.7208). CONCLUSIONS: Systematic screening and treatment of asymptomatic carriers at the community level did not reduce clinical malaria incidence in the subsequent transmission season, indicating greater levels of parasite clearance are required to achieve a sustained impact in this setting.
format Online
Article
Text
id pubmed-3599538
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35995382013-03-17 A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso Tiono, Alfred B Ouédraogo, Alphonse Ogutu, Bernhards Diarra, Amidou Coulibaly, Sam Gansané, Adama Sirima, Sodiomon B O’Neil, Gregory Mukhopadhyay, Amitava Hamed, Kamal Malar J Research BACKGROUND: In malaria-endemic countries, large proportions of infected individuals are asymptomatic, constituting a reservoir of parasites for infection of newly hatched mosquitoes. This study evaluated the impact of screening and treatment of asymptomatic carriers of Plasmodium falciparum. METHODS: Eighteen villages were randomized (1:1) to study arms and inhabitants participated in four community screening campaigns: three before the rainy season ~1 month apart, and the fourth after the rains at ~12 months. On day 1 of campaigns 1–3, asymptomatic carriers in the intervention arm were identified by rapid diagnostic test and treated with artemether-lumefantrine. Outcomes were symptomatic malaria with parasite density >5,000/μL per person-year in children < 5 years and change in haemoglobin between days 1 and 28 of campaign 1. RESULTS: At 12 months, the number of symptomatic malaria episodes with a parasite density >5,000/μL per person-year in children < 5 years was not significantly different between arms (1.69 vs 1.60, p = 0.3482). Mean haemoglobin change in asymptomatic carriers during campaign 1 was greater in the intervention vs control arm (+0.53 g/dL vs -0.21 g/dL, p < 0.0001). ANCOVA demonstrated that mean asymptomatic carriage at the cluster level was lower in the intervention vs control arm at day 1 of campaigns 2 (5.0% vs 34.9%, p < 0.0001) and 3 (3.5% vs 31.5%, p < 0.0001), but showed only a small difference at day 1 of campaign 4 (34.6% vs 37.6%, p = 0.2982). Mean gametocyte carriage was lower in the intervention vs control arm at day 1 of campaigns 2 and 3 (0.7% vs 5.4%, p < 0.0001; 0.5% vs 5.8%, p < 0.0001), but was similar at day 1 of campaign 4 (4.9% vs 5.1%, p = 0.7208). CONCLUSIONS: Systematic screening and treatment of asymptomatic carriers at the community level did not reduce clinical malaria incidence in the subsequent transmission season, indicating greater levels of parasite clearance are required to achieve a sustained impact in this setting. BioMed Central 2013-02-27 /pmc/articles/PMC3599538/ /pubmed/23442748 http://dx.doi.org/10.1186/1475-2875-12-79 Text en Copyright ©2013 Tiono et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tiono, Alfred B
Ouédraogo, Alphonse
Ogutu, Bernhards
Diarra, Amidou
Coulibaly, Sam
Gansané, Adama
Sirima, Sodiomon B
O’Neil, Gregory
Mukhopadhyay, Amitava
Hamed, Kamal
A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title_full A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title_fullStr A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title_full_unstemmed A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title_short A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
title_sort controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of plasmodium falciparum in burkina faso
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599538/
https://www.ncbi.nlm.nih.gov/pubmed/23442748
http://dx.doi.org/10.1186/1475-2875-12-79
work_keys_str_mv AT tionoalfredb acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT ouedraogoalphonse acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT ogutubernhards acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT diarraamidou acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT coulibalysam acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT gansaneadama acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT sirimasodiomonb acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT oneilgregory acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT mukhopadhyayamitava acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT hamedkamal acontrolledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT tionoalfredb controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT ouedraogoalphonse controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT ogutubernhards controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT diarraamidou controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT coulibalysam controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT gansaneadama controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT sirimasodiomonb controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT oneilgregory controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT mukhopadhyayamitava controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso
AT hamedkamal controlledparallelclusterrandomizedtrialofcommunitywidescreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparuminburkinafaso